From ABP Investments and others.

Sir, We write to express our full support for the comments made in your editorial "Why the animal rights fanatics are wrong" (May 10). As major institutional investors in companies legitimately engaged in lawful research to the benefit of society, we intend to stand firm alongside the small shareholders in GlaxoSmithKline who have been targeted for bullying in the current campaign.